MarketLens

What Makes Silk Road Medical's TCAR a Game Changer in Carotid Artery Disease Treatment

6 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

Already a Pro member? Log in

SHARE THIS ON:

What Makes Tethis' SmartBioSurface® a Game-Changer in Cell Analysis

4 months ago

What Makes Precision Health's New Patent a Game-Changer

6 months ago

What Makes Cytokinetics' MYQORZO Launch a Game Changer

8 months ago

What Makes Google's Lyria 3 Pro a Game Changer for AI Music

6 months ago

SirPAD Subgroup Study at VIVA 2026 Focuses on Femoropopliteal PAD in Patients With Claudication

SirPAD randomized 1,252 patients with symptomatic infrainguinal PAD to angioplasty using Concept Medical's MagicTouch sirolimus-coated balloon, with a femoropopliteal claudication subgroup analysis pr...

Stock News•2 months ago

HighLife Receives CE Mark Approval for Clarity Valve, the Next-Generation Valve for the HighLife TMVR System

HighLife SAS received CE Mark approval for its Clarity Mitral Heart Valve, enabling use with the HighLife TMVR System to treat mitral regurgitation. The approval, announced August 27, 2026, clears the...

Stock News•2 months ago

Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”

A Phoenix vascular surgeon performed Arizona's first commercial Symvess implantation, the first FDA-approved bioengineered human blood vessel. The procedure marks a commercial milestone for the device...

HUMA

Breaking News

Top Headlines

View More →

Stock News•26 minutes ago

Google parent Alphabet suffers nearly $500B Wall Street wipeout amid AI spending fears

Stock News•53 minutes ago

Amazon the Latest Mag 7 to Miss Q3 Estimates

Stock News•1 hour ago

20 Years of S&P 500 History Show: This Simple Strategy Is Only 8.3% Less Than "Perfect"

Stock News•1 hour ago

Microsoft Q1: Capex Shouldn't Scare You Due To Free Cash Flow

Stock News•1 hour ago

What Makes Silk Road Medical's TCAR a Game Changer in Carotid Artery Disease Treatment

Exclusive Content for Pro Members

Related Articles

What Makes Tethis' SmartBioSurface® a Game-Changer in Cell Analysis

What Makes Precision Health's New Patent a Game-Changer

What Makes Cytokinetics' MYQORZO Launch a Game Changer

What Makes Google's Lyria 3 Pro a Game Changer for AI Music

Category

You may also like

SirPAD Subgroup Study at VIVA 2026 Focuses on Femoropopliteal PAD in Patients With Claudication

HighLife Receives CE Mark Approval for Clarity Valve, the Next-Generation Valve for the HighLife TMVR System

Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”

Breaking News

Featured Articles

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

Top Headlines

Google parent Alphabet suffers nearly $500B Wall Street wipeout amid AI spending fears

Amazon the Latest Mag 7 to Miss Q3 Estimates

20 Years of S&P 500 History Show: This Simple Strategy Is Only 8.3% Less Than "Perfect"

Microsoft Q1: Capex Shouldn't Scare You Due To Free Cash Flow

Microsoft Took The Balanced Approach To AI - Now It's The King